Streetbeat News

Stock Prices

JLL

Jones Lang LaSalle (JLL) reported Q4 2023 adjusted EPS of $4.23, surpassing the $3.74 estimate, with sales of $2.18B also beating the $2.08B estimate. However, this represents a 1.54% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 12:33 pm

VRPX

Virpax Pharmaceuticals announced a 1-for-10 reverse stock split effective March 1, 2024, aimed at regaining compliance with Nasdaq's minimum bid price requirement.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 12:33 pm

TWKS

Thoughtworks has projected its Q1 revenue to be between $241M-$246M, which is below the expected $267.56M. Additionally, the company anticipates an adjusted loss of $(0.02)-$(0.01) per share, contrary to the estimated earnings of $0.05 per share.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 12:31 pm

DKL

Delek Logistics Partners (DKL) reported Q4 earnings of $0.51 per share, missing the consensus estimate of $0.89 by 42.7%, and a 47.96% decrease from last year's $0.98. Quarterly sales were $254.15M, missing the $278.26M estimate by 8.66%, and a 5.54% decrease from last year's $269.05M.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 12:31 pm

CMND

SPRC

Clearmind Medicine Inc (NASDAQ:CMND) and SciSparc Ltd (NASDAQ:SPRC) have submitted three new international patent applications for MDMA, Ibogaine, and Ketamine compounds in collaboration. These applications aim to expand their intellectual property in the psychedelic space, with Clearmind now holding 27 granted patents and 24 pending applications. Additionally, Clearmind received approval to commence a phase 1/2a trial in Israel for alcohol use disorder using its CMND-100 oral capsule. CMND shares dropped 1.73% in premarket trading.

Portfolio Pulse from Vandana Singh

February 27, 2024 | 12:30 pm

DPZ

Argus Research analyst John Staszak has upgraded Domino's Pizza (DPZ) from Hold to Buy while maintaining the price target at $530.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 12:29 pm

MDRX

Veradigm announced it will not meet Nasdaq's deadline of February 27, 2024, for filing required financial statements, risking suspension of trading. The company is working to file the necessary documents and has adopted a stockholder rights plan in anticipation of potential trading suspension.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 12:25 pm

TWKS

Thoughtworks Holding (TWKS) reported Q4 earnings of $0.02 per share, missing the consensus estimate of $0.03, and sales of $252.39M, missing the estimate of $267.55M. This represents an 80% decrease in earnings and an 18.78% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 12:24 pm

SEE

Sealed Air projects its FY24 adjusted EPS to range between $2.65 and $3.05, compared to the $3.03 estimate. The company also forecasts FY24 net sales to be between $5.2B and $5.6B, against the $5.5B estimate.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 12:12 pm

STGW

Stagwell forecasts a 5%-7% organic net revenue growth for 2024, with an adjusted EPS range of $0.75-$0.88, which is below the estimated $0.91.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 12:11 pm